# Jos Jonkers

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/jos-jonkers/

## Facts

| Field | Value |
| --- | --- |
| Citations | 56,183 |
| Field | PARP inhibition in cancer therapy |
| h-index | 110 |
| i10-index | 291 |
| Last Known Institution | Dutch Cancer Society |
| OpenAlex ID | https://openalex.org/A5061340130 |
| ORCID iD | https://orcid.org/0000-0002-9264-9792 |
| Works | 847 |

## Researcher papers

- [Landscape of somatic mutations in 560 breast cancer whole-genome sequences](https://scholariq.org/papers/landscape-of-somatic-mutations-in-560-breast-cancer-whole-genome-sequences/)
- [Interrogating open issues in cancer precision medicine with patient-derived xenografts](https://scholariq.org/papers/interrogating-open-issues-in-cancer-precision-medicine-with-patient-derived/)

## Researcher topics

- [PARP inhibition in cancer therapy](https://scholariq.org/topics/parp-inhibition-in-cancer-therapy/)
- [CRISPR and Genetic Engineering](https://scholariq.org/topics/crispr-and-genetic-engineering/)
- [DNA Repair Mechanisms](https://scholariq.org/topics/dna-repair-mechanisms/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [BRCA gene mutations in cancer](https://scholariq.org/topics/brca-gene-mutations-in-cancer/)

## Researcher university

- [Dutch Cancer Society](https://scholariq.org/institutions/dutch-cancer-society/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.